January 28, 2011 — The Advisory Committee on Immunization Practices (ACIP) has updated its recommendations for use of meningococcal conjugate vaccines and published the new guidelines in the January ...

Quadrivalent meningococcal conjugate vaccine (MenACWY-D; Menactra, sanofi pasteur) appears to be safe and immunogenic when given as a 2-dose series in infants at the age of 9 months and 1 year, ...

...this study is the first clear demonstration of the vaccine's efficacy A collaboration between the African Meningococcal Carriage Consortium (MenAfriCar), the Meningitis Vaccine Project and ...

Review the side-effects of Meningococcal Conjugate Vaccine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication ...

Background. Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub-Saharan region of Africa in the meningitis belt. Neisseria meningitidis is an encapsulated pathogen ...

(RTTNews) - Sanofi said that the U.S. Food and Drug Administration has approved a Biologics License Application for MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive ...

Under the new guidelines, the CDC recommends all children be vaccinated against 11 diseases, a decrease from the 17 ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

Neisseria meningitidis is a gram-negative diplococcus, which like all gram-negative bacteria, possesses a lipopolysaccharide-like component in its outer cell membrane. Almost all invasive isolates of ...

Please provide your email address to receive an email when new articles are posted on . The FDA has recently approved MenQuadfi, a meningococcal conjugate vaccine that protects against serogroups A, C ...